Pfenex Inc.
PFNX
PFNX was delisted on the 30th of September, 2020.
99 hedge funds and large institutions have $276M invested in Pfenex Inc. in 2019 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 35 increasing their positions, 32 reducing their positions, and 8 closing their positions.
379% more call options, than puts
Call options by funds: $1.34M | Put options by funds: $279K
188% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 8
31% more capital invested
Capital invested by funds: $211M → $276M (+$65.1M)
16% more funds holding
Funds holding: 85 → 99 (+14)
9% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 32
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$6.11M |
| 2 |
SMH
Sanders Morris Harris
Houston,
Texas
|
+$3.86M |
| 3 |
Jane Street
New York
|
+$2.63M |
| 4 |
Nuveen
Charlotte,
North Carolina
|
+$2.52M |
| 5 |
TAM
Telemark Asset Management
Boston,
Massachusetts
|
+$1.84M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCC
Dow Chemical Company
Midland,
Michigan
|
-$6.95M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$5.06M |
| 3 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$4.96M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$3.32M |
| 5 |
RCMC
RK Capital Management (Colorado)
Denver,
Colorado
|
-$1.74M |
PFNX Hedge Fund Activity: Q4 2019 in Review
99 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Pfenex Inc. (PFNX) for Q4 2019, worth a combined $276M — up 31% from $211M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new PFNX positions and 8 closed out — a net gain of 15 holders — while 35 added to existing stakes and 32 trimmed.
The largest buyer was OrbiMed, opening a new position worth an estimated $6.11M. The largest seller was Dow Chemical Company, cutting an estimated $6.95M.
- 99 institutional investors held Pfenex Inc. (PFNX) as of Q4 2019, up from 85 in Q3 2019.
- Funds reported $276M of Pfenex Inc. stock for Q4 2019, up 31% quarter-over-quarter.
- 23 funds opened new Pfenex Inc. positions in Q4 2019 and 8 closed out, a net change of +15 holders.
- The largest Pfenex Inc. buyer in Q4 2019 was OrbiMed, an estimated $6.11M added.
- The largest Pfenex Inc. seller in Q4 2019 was Dow Chemical Company, an estimated $6.95M sold.
Based on aggregated 13F filings for Q4 2019.